Genetic and cellular drivers of the cellular uptake of SARS-CoV-2 can be screened at high throughput via droplet microfluidics and size-exclusion methods for the analysis of the formation of fusions between cells expressing the virus’s spike protein and cells expressing the protein’s receptor.
This is a preview of subscription content, log in via an institution to check access.
References
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Nat. Rev. Microbiol. 19, 155–170 (2021).
Braga, L. et al. Nature 594, 88–93 (2021).
Sanders, D. W. et al. eLife 10, e65962 (2021).
Francino-Urdaniz, I. M. et al. Cell Rep. 36, 109627 (2021).
Merten, C. A. et al. J. Virol. 79, 834–840 (2005).
Chan, C. W. F. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01140-z (2023).
Gérard, A. et al. Nat. Biotechnol. 38, 715–721 (2020).
El Debs, B., Utharala, R., Balyasnikova, I. V., Griffiths, A. D. & Merten, C. A. Proc. Natl Acad. Sci. USA 109, 11570–11575 (2012).
Eduati, F. et al. Nat. Commun. 9, 2434 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Autour, A., Merten, C.A. Screening for drivers of SARS-CoV-2 uptake. Nat. Biomed. Eng 8, 205–206 (2024). https://doi.org/10.1038/s41551-023-01170-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-023-01170-7
- Springer Nature Limited